Experimental drug slows progression of early Alzheimer's disease by 60%, study finds

https://ift.tt/xdLf2wV Eli Lilly's experimental drug donanemab slowed the progression of Alzheimer's by 60% for patients in the earliest stages of the brain-wasting disease, according to trial data presented at a medical meeting on Monday. 

from France 24 - International breaking news, top stories and headlines https://ift.tt/iweTqsP

Commentaires

Posts les plus consultés de ce blog

Turkey's fourth largest city at risk as wildfires sweep southern Europe

Retired French surgeon accused of abusing hundreds of children ‘ready to admit’ to some rapes

US military hits over 800 targets in Yemen since March, hundreds of Houthi rebels killed